Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Review

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

Authors

L H Calabrese PubMed articles Google scholar articles
N N Zein PubMed articles Google scholar articles
D Vassilopoulos PubMed articles Google scholar articles

Correspondence to:
Dr L H Calabrese
DO, Department of Rheumatic and Immunological Disease, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA; calabrl{at}ccf.org

Citation

Calabrese LH, Zein NN, Vassilopoulos D

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

Annals of the Rheumatic Diseases 2006;65:983-989.

Publication history

Accepted March 5, 2006
First published April 20, 2006.

Online issue publication

April 13, 2016

Copyright information

Copyright 2006 by Annals of the Rheumatic Diseases